Current therapeutic strategies for diabetes aim to control carbohydrate homeostasis, mostly through the delivery of exogenous insulin, the use of drugs to stimulate insulin production and secretion by the diminishing β-cell mass, and therapeutic agents inhibiting glucagon secretion (Marín-Peñalver et al., 2016). The gene discussed is INS; the disease is diabetes mellitus.